chr2-73385903-T-TGGAGGAGGAGGAGGAGGAGGAGGA
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP3BP6
The NM_001378454.1(ALMS1):c.51_74dup(p.Glu21_Glu28dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000028 ( 0 hom., cov: 0)
Exomes 𝑓: 0.000057 ( 0 hom. )
Consequence
ALMS1
NM_001378454.1 inframe_insertion
NM_001378454.1 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.369
Genes affected
ALMS1 (HGNC:428): (ALMS1 centrosome and basal body associated protein) This gene encodes a protein containing a large tandem-repeat domain as well as additional low complexity regions. The encoded protein functions in microtubule organization, particularly in the formation and maintanance of cilia. Mutations in this gene cause Alstrom syndrome. There is a pseudogene for this gene located adjacent in the same region of chromosome 2. Alternative splice variants have been described but their full length nature has not been determined. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001378454.1
BP6
Variant 2-73385903-T-TGGAGGAGGAGGAGGAGGAGGAGGA is Benign according to our data. Variant chr2-73385903-T-TGGAGGAGGAGGAGGAGGAGGAGGA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 917603.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ALMS1 | NM_001378454.1 | c.51_74dup | p.Glu21_Glu28dup | inframe_insertion | 1/23 | ENST00000613296.6 | |
ALMS1 | NM_015120.4 | c.51_74dup | p.Glu21_Glu28dup | inframe_insertion | 1/23 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ALMS1 | ENST00000613296.6 | c.51_74dup | p.Glu21_Glu28dup | inframe_insertion | 1/23 | 1 | NM_001378454.1 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000279 AC: 4AN: 143532Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
4
AN:
143532
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000574 AC: 32AN: 557738Hom.: 0 Cov.: 0 AF XY: 0.0000369 AC XY: 11AN XY: 297828
GnomAD4 exome
AF:
AC:
32
AN:
557738
Hom.:
Cov.:
0
AF XY:
AC XY:
11
AN XY:
297828
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000278 AC: 4AN: 143636Hom.: 0 Cov.: 0 AF XY: 0.0000431 AC XY: 3AN XY: 69662
GnomAD4 genome
AF:
AC:
4
AN:
143636
Hom.:
Cov.:
0
AF XY:
AC XY:
3
AN XY:
69662
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
ALMS1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 23, 2023 | The ALMS1 c.54_74dup21 variant is predicted to result in an in-frame duplication (p.Glu22_Glu28dup). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Alstrom syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 04, 2022 | This variant, c.54_77dup, results in the insertion of 8 amino acid(s) of the ALMS1 protein (p.Glu22_Glu29dup), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ALMS1-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 06, 2020 | Variant summary: The ALMS1 variant, c.54_74dup21 (p.Glu22_Glu28dup) is located in a Glu repetitive region (Glu13_Glu28). The variant was absent in 83366 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. No variants located in this Glu repetitive region were reported in HGMD database and other variants (including deletion and duplication) located in this repetitive region were reported in LOVD database and classified as likely benign/benign. In addition, other duplication variants (p.Glu26_Glu28dup, p.Glu23_Glu24dup, p.Glu24dup) located in this Glu repetitive region have been classified as benign by our laboratory. To our knowledge, no occurrence of c.54_74dup21 in individuals affected with Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at